Naglaa Afifi

Naglaa Afifi

Auto-generated profile, based on publicly available information

Naglaa Afifi

Department of Internal Medicine and Rheumatology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Open Access Rheumatology: Research and Reviews
Verified
Journal Article
Open access
PDF file
NANaglaa Afifi
Naglaa Afifi
BMBasma M Medhat
Basma M Medhat
AGAmani Mohamed Abdel Ghani
Amani Mohamed Abdel Ghani
HHHend Galal Eldeen Mohamed Ali Hassan
Hend Galal Eldeen Mohamed Ali Hassan
MBMervat E Behiry
Mervat E Behiry
Purpose: To evaluate the albumin-fibrinogen ratio (AFR) and C-reactive protein-albumin ratio (CAR) as inflammatory markers in rheumatoid arthritis (RA) and to investigate their association with disease activity correlating with musculoskeletal ultrasonographic findings. Patients and Methods: A total of 125 cases of RA patients were consecutively enrolled in a multicenter cross-sectional study compared to 100 healthy controls, all subjects were investigated for fibrinogen, albumin, CRP, erythrocyte sedimentation rate, AFR, and CAR measurements. Patients’ disease activity was assessed by disease activity score (DAS28-ESR), and they were subjected to high-frequency ultrasound both in greyscale and power Doppler. Results: RA patients had lower AFR and higher CAR than those in the control group (P < 0.001). A positive correlation was demonstrated between CAR and DAS score (r=0.589, P = 0.0001), whilst there was a precise negative correlation between AFR and DAS 28-ESR (r=− 0.74, p< 0.001). ROC curve analyses revealed fibrinogen showed the best sensitivity (92.1%) for the area under the curve of 0.928, at a criterion of 2.47, while AFR has an area under the curve of 0.826 with sensitivity and specificity (86.84% and 75%, respectively) at cut-off value 1.46. Actively diseased patients had elevated CAR than those in remission (P < 0.001). Patients with synovial thickening and bone erosions had lower AFR than those without, CAR was higher in patients with power doppler changes than those without (p=0.015). Conclusion: Higher CAR and lower AFR were expressed in active RA than those in remission. CAR and AFR could be useful markers of ongoing inflammation and joint affection detected by musculoskeletal ultrasonography.

8 September 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
NANaglaa Afifi
Naglaa Afifi
MKMaha Mohamed Mohamed Khalifa
Maha Mohamed Mohamed Khalifa
AAAlaa Allah Mohamed Mohamed Mahmoud Al Anany
Alaa Allah Mohamed Mohamed Mahmoud Al Anany
HHHend Galal Eldeen Mohamed Ali Hassan
Hend Galal Eldeen Mohamed Ali Hassan

14 January 2021 in Infectious Diseases in Clinical Practice
Verified
Journal Article
Closed access
HKHend Kandil
Hend Kandil
AIAhmed Elsayed Ibrahim
Ahmed Elsayed Ibrahim
NANaglaa Afifi
Naglaa Afifi
AAAhmed Md Arafa
Ahmed Md Arafa
An abstract is unavailable. This article is available as a PDF only.

1 December 2020 in The Egyptian Journal of Internal Medicine
Verified
Journal Article
Open access
HMHowaida E. Mansour
Howaida E. Mansour
RHReem A. Habeeb
Reem A. Habeeb
NENoran O. El-Azizi
Noran O. El-Azizi
HAHeba H. Afeefy
Heba H. Afeefy
MNMarwa A. Nassef
Marwa A. Nassef
NANaglaa Afifi
Naglaa Afifi
Background: Neuropsychiatric manifestations are frequently reported in systemic lupus erythematosus (SLE) patients. This study was done to describe electroencephalographic (EEG) findings in SLE patients with neuropsychiatric manifestation (NPSLE). Results: Among 60 SLE patients, there were 50 females (83.3%) and 10 males (16.7%). EEG abnormalities were reported in 12 patients out of 30 (40%) with NPSLE, while all patients with non-NPSLE (n = 30) had no EEG abnormalities; diffuse slowing (20%) was the most common abnormalities, followed by generalized epileptiform activity (13.3%), and lastly temporal epileptiform activity (6.7%). Seizure was the most reported neuropsychiatric disorder in 13 patients (43.3%); 8 of them had abnormal EEG (61.5%). Periventricular white matter lesion (23.3%) followed by infarction (13.3%) were the most common MRI brain findings among 53.3% of NPSLE group. Half of the cases with EEG abnormality had normal brain MRI. SLEDAI score and ACL IgM positivity were higher in the NPSLE group than the non-NPSLE group. EEG is not a sensitive or specific test for detecting NPSLE with sensitivity (37.5%) and specificity (57.1%). Conclusion: Not all patients with NPSLE must have abnormal brain MRI or EEG. EEG is a useful assistant tool in the assessment of different manifestations of NPSLE, but it cannot be used as a screening test alone and must be supplemented by neuroimaging studies.

10 July 2025 in Journal of Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
NANaglaa Afifi
Naglaa Afifi
KSKareem Ahmed Abdelaziz Sabry
Kareem Ahmed Abdelaziz Sabry
DSDalia Salah Saif
Dalia Salah Saif
RHRasha Mohamed Hassan
Rasha Mohamed Hassan
RERahma A. Elziaty
Rahma A. Elziaty
Naglaa Afifi, M.D., Kareem Ahmed Abdelaziz Sabry, M.D., Dalia Salah Saif, M.D., Rasha Mohamed Hassan, M.D., Rahma Ahmed Elziaty, M.D.. J Rheum Dis 2025;32:283-91. https://doi.org/10.4078/jrd.2025.0016

23 March 2026 in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
Verified
Journal Article
Closed access
NANermeen Noshy Aziz
Nermeen Noshy Aziz
RHRasha Mohamed Hassan
Rasha Mohamed Hassan
RIRehab Ali Ibrahim
Rehab Ali Ibrahim
NANaglaa Afifi
Naglaa Afifi
RTRasha N Thabet
Rasha N Thabet
Background: Late-onset rheumatoid arthritis (LORA) poses a great challenge for physicians regarding diagnosis and treatment. The prognosis for LORA was better in some early research but worse in more recent trials. Objectives: The study aim was to compare the clinical, laboratory, and radiological characteristics assessed by musculoskeletal ultrasound (MSUS) of patients with LORA and early-onset rheumatoid arthritis (EORA) and to examine their associations with inflammation and treatment outcomes. Design: The study included 64 RA with EORA and 64 RA patients with LORA, fulfilling the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) 2010 criteria for RA. Methods: Medical history, Health Assessment Questionnaire Disability Index (HAQ-DI), DAS 28 score, laboratory investigations, and MSUS of both hands and wrist joints were done. Results: Female patients with EORA were more compared with those with LORA (89% vs 78.1%). Comorbidities were significantly more prevalent in the LORA group (28.12%) compared with the EORA group (10.9%) ( P = .0143). A significant difference was also observed between the 2 groups regarding higher ESR values in LORA, with no significant difference detected in C-reactive protein (CRP) levels. Regarding joint involvement, shoulder, metatarsophalangeal (MTP), and knee joints were more frequently affected in LORA, with statistically significant differences ( P < .0001, .0119, and .0285, respectively). The MSUS findings revealed higher gray-scale grades in patients with LORA, with significantly increased Doppler signal activity ( P < .052), and a greater frequency of erosions compared with those with EORA. The mean HAQ-DI score was significantly higher in LORA than in EORA ( P = .0004). Regarding treatment patterns, methotrexate (MTX) was more commonly prescribed in the EORA group (67.1%) compared with the LORA group (37.5%), whereas leflunomide was used more in LORA (68.75%) compared with EORA (46.8%), with statistically significant difference. Conclusions: Patients with LORA demonstrated more active synovitis and a higher frequency of erosions compared with those with EORA, despite the non-significant difference in DAS 28 scores. Moreover, patients with LORA exhibited a greater burden of comorbidities than those with EORA. Therefore, regular evaluation of inflammatory activity using MSUS, along with assessment of associated comorbid conditions, is recommended in patients with LORA.